Prescription drug price transparency
The following resources are for reporting entities who may need assistance with prescription drug price transparency.
On this page
Want to stay up-to-date on prescription drug price transparency?
Reporting entity resources (carriers, manufacturers, PBMs, PSAOs)
The following resources are for reporting entities who may need assistance.
The excel templates below are available as an aid if you are hand-keying data for submissions to the Drug Price Transparency program. These workbooks are programmed with simple rules that will help you avoid some common errors that can occur.
Important note about Excel version: We recommend using Microsoft Excel 2016 or earlier for the submission guides. Using Microsoft Excel 2019 can cause formatting issues when saving as a CSV file.
New DPT login process
Starting November 15, reporting entities can log into HCA Support to enter their data for the DPT program. You will need a SecureAccess Washington (SAW) account to login.
- View instructions for setting up a SAW account and accessing HCA Support.
- View step-by-step instructions for accessing the DPT reporting forms through HCA Support.
All
-
Data submission FAQ (updated 12/1/2021)
Carriers
Report year 2022
- Data submission guide draft (Comments due by April 6, 2023)
- Change summary
Report year 2021
- Change summary
- Data submission guide
- Cost utilization template
- Premium impact template
- Specialty drug list template
Report year 2020
- Data submission guide
- Cost utilization template
- Premium impact template
- Specialty drug list template
Manufacturers
Report year 2023
Effective February 1, 2023.
- Change summary
- Data submission guide
- Price increase template (new)
- New covered drugs template (revised)
- New drugs template
Pharmacy Benefit Managers (PBMs)
Report year 2021
Report year 2020
Report years 2018-2019
Pharmacy Services Administrative Organizations (PSAOs)
Report year 2022
- Data submission guide draft (Comments due by April 6, 2023)
- Change summary
Report year 2021
- Data submission guide
- Pharmacy benefit manager contracted rates template
- Pharmacy benefit manager year-over-year rate change template
- Pharmacy contracted rates template
- Pharmacy year-over-year rate change template
Report year 2020
- Data submission guide
- Pharmacy benefit manager contracted rates template
- Pharmacy benefit manager year-over-year rate change template
- Pharmacy contracted rates template
- Pharmacy year-over-year rate change template
Stakeholder meetings
At each meeting, HCA will give a short overview of Chapter 43.71C RCW then use the majority of time to take questions and hear concerns from stakeholders. We will focus on a different supplier in each meeting. The public is invited to participate in any of the meetings.
Meeting schedule
| Date and time | Meeting type | Materials |
|---|---|---|
| July 28, 2021 | PBM listening session | |
| July 22, 2021 | Manufacturer listening session | |
| July 6, 2021 | Carrier listening session | |
| April 29, 2020 |
Pharmacy benefit manager / pharmacy service administrative organization reporting Webinar only, no in person meeting due to COVID-19 |
|
| April 1, 2020 |
Issuer / carrier reporting Webinar only, no in person meeting due to COVID-19 |
Updated slide deck |
| February 26, 2020 | Manufacturer reporting |
Background
In 2019, the Washington State Legislature passed Engrossed Second Substitute House Bill into law. This law requires issuers of health insurance, pharmacy benefit managers (PBMs), manufacturers, and pharmacy service administrative organizations (PSAOs) to submit data to the Health Care Authority (HCA). The purpose is to create an annual report on how prescription drugs affect health care costs. The law also requires pharmaceutical manufacturers to submit data to HCA relating the new drug applications (NDA).
Reports
Annual reports created by HCA to detail the current state of the program as the agency begins to receive drug pricing and cost data.
Contact
Program questions and information
Email: HCA Drug Price Transparency - general inquiry
Technical data related questions, or any questions regarding the data submission process
Email: HCA Drug Price Transparency - tech support
Protections for insurance consumers and insurance industry oversight
Contact: Washington State Office of the Insurance Commissioner (OIC)